FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy
Fierce Pharma
MAY 31, 2023
FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy kdunleavy Wed, 05/31/2023 - 13:02
Sat.May 27, 2023 - Fri.Jun 02, 2023
126 
Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID
Drug Topics
JUNE 2, 2023
New research suggests that chronotropic incompetence contributes to exercise limitations in Long COVID.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
ICYMI: PBM exec admits choosing profits over patients
PhRMA
JUNE 2, 2023
With Congress discussing policy changes that would lower drug costs for patients and rein in powerful middlemen, insurers and their PBMs are dusting off their old playbook and once again threatening to increase costs for employers if required to do their job and actually provide meaningful coverage to patients. But recent remarks by one executive make clear that the PBM industry has a choice: protect its profits or lower costs for patients.
A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking
PharmaVoice
JUNE 2, 2023
Healthcare pros share the market drivers they believe are having the biggest impact on the industry.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
COVID-19 Infection Could Be Detected in Lungs, Heart, Causing Inflammatory Damage
Pharmacy Times
JUNE 2, 2023
Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.
Efficacy of Therapeutic Cannabis in Patients With Medically Diagnosed Conditions
Drug Topics
JUNE 1, 2023
A majority of patients say that taking cannabis helps them with chronic pain management and other conditions.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Woman of the Week: Mirati Therapeutics’ Laurie Stelzer
PharmaVoice
MAY 31, 2023
With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial-based organization.
The Latest in the Role of Pharmacogenomics in Mental Health Treatment
Pharmacy Times
JUNE 1, 2023
Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.
FDA: Pfizer RSV Vaccine Approved for Use In Older Adults
Drug Topics
JUNE 1, 2023
Abrysvo is the second RSV vaccine approved by the FDA.
Firstline As A City-Wide Platform To Support Antimicrobial Stewardship: Insights From New York City
IDStewardship
JUNE 1, 2023
In this article the adoption of Firstline as a city-wide platform to support antimicrobial stewardship in collaboration with New York City Department of Health and Mental Hygiene is discussed. Interview with: William Greendyke, M.D. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 3 June 2023 We have come a long way since the term “ Antimicrobial Stewardship ” first appeared in the medical literature in 1996, brought to us by John McGowan and Dale Gerding.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
CVS is exiting clinical trials. Does this spell trouble for retail-based research?
PharmaVoice
MAY 30, 2023
Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.
Pharma giant Bayer moves deeper into digital health with new business unit
Fierce Healthcare
JUNE 2, 2023
Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools. | Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools.
The Chronic Complications For Children With T1DM
Drug Topics
MAY 30, 2023
Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
STAT+: Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts
STAT
JUNE 1, 2023
In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira — one of the world’s best-selling medicines — at a steep discount, and will work with Mark Cuban’s generic drug company to make the medicine available directly to consumers for even less. Specifically, the Coherus medicine will carry a $995 list price for a carton of two autoinjectors, an 85% discount from the $6,922 that AbbVie charges for Humira, which is used to treat rheumatoid arthri
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA Approves Abrysvo to Prevent Respiratory Syncytial Virus in Older Adults
Pharmacy Times
JUNE 1, 2023
Pfizer Inc’s bivalent respiratory syncytial virus (RSV) vaccine Abrysvo is indicated to prevent lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
Medicare to broaden coverage of Alzheimer’s drugs after full FDA approval, but with some restrictions
Fierce Healthcare
JUNE 1, 2023
The Centers for Medicare and Medicaid Services outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration | CMS outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration.
Drug Manufacturer Coupons: Charitable Assistance or Marketing Tool?
Drug Topics
MAY 31, 2023
The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.
How Takeda finds the hottest new science to fuel its oncology work
PharmaVoice
JUNE 1, 2023
Takeda's president of the global oncology business unit is always "scanning the horizon" for the partnerships that will drive the next big innovations.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Study: Oral Semaglutide Leads to Significant Weight Loss in 89.2% of Individuals in Trial
Pharmacy Times
MAY 30, 2023
Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.
Discrimination, racism, violence are common and weighing heavily on healthcare workers, surveys show
Fierce Healthcare
JUNE 1, 2023
A pair of new healthcare workforce surveys outline widespread reports of discrimination, racism and workplace violence perpetuated by patients and coworkers alike. | A pair of polls released this week detail the interpersonal difficulties nurses and other healthcare workers face in the workplace.
Coherus Biosciences Joins Forces With Mark Cuban’s Online Pharmacy for Humira Biosimilar
Drug Topics
JUNE 2, 2023
Yusimry (adalimumab-aqvh) is 1 of 9 FDA-approved adalimumab biosimilars and is a low-concentration, citrate-free product.
Lawmakers look to crack down on Big Pharma tax breaks
PharmaVoice
MAY 31, 2023
As lawmakers shine a light on Big Pharma tax cuts, the industry’s business moves are coming under attack from multiple angles.
Clinical Overview: Biologic Agents for the Treatment of Crohn Disease
Pharmacy Times
MAY 31, 2023
As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.
Denials of health insurance claims are rising—and getting weirder
Fierce Healthcare
MAY 30, 2023
Denials of health insurance claims are rising—and getting weirder pminemyer Tue, 05/30/2023 - 10:51
How Does Digital Data Help Improve QOL in Patients With Long COVID and Autoimmune Diseases?
Drug Topics
MAY 30, 2023
Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
ASCO: Novartis pressures Lilly with Kisqali, targeting $3B opportunity in early breast cancer
Fierce Pharma
MAY 31, 2023
Adding Kisqali to endocrine therapy after surgery reduced the risk of invasive tumor recurrence or death by 25% in certain early-stage breast cancers.
Interactive Case Studies: May 2023
Pharmacy Times
MAY 29, 2023
Cases address gastrointestinal issues and alcohol abuse.
Long COVID described as a 'syndrome of syndromes' in NIH funded research
Fierce Healthcare
MAY 30, 2023
Long COVID described as a 'syndrome of syndromes' in NIH funded research fdiamond Tue, 05/30/2023 - 12:16
Support your Pharmacy’s Just Culture Journey
Drug Topics
MAY 31, 2023
Pharmapod’s Incident Management reporting platform + Patient Safety Organization improves processes to enhance medication and patient safety
STAT+: Tempus launches an AI ‘assistant’ for thousands of oncologists
STAT
JUNE 1, 2023
Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that it is launching a voice-and-text assistant called Tempus One that will give physicians much easier access to patient data. The AI assistant is being launched ahead of the annual meeting of the American Society of Clinical Oncology in Chicago. Eric Lefkofsky, Tempus’ founder and CEO, told STAT Tempus will be rolling the product, called Tempus One, out to the 6,000 doctors that prescri
FDA Approves Olaparib Plus Abiraterone, Prednisone for Metastatic Castration-Resistant Prostate Cancer
Pharmacy Times
JUNE 1, 2023
Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.
Oak Street Health unveils expansion plans to open centers in 4 new states
Fierce Healthcare
JUNE 1, 2023
Less than a month after CVS Health acquired Oak Street Health, the primary care provider plans to expand into four more states. | The company plans to open value-based primary care centers in Little Rock, Arkansas; Des Moines and Davenport, Iowa; Kansas City, Kansas and Richmond, Virginia, beginning this summer. Oak Street Health will operate centers in 25 states by the end of the year.
Biosimilars Are Not Having a Big Impact on Insulin Prices
Drug Topics
JUNE 1, 2023
Years of steady price increases have made access to the essential medicine more difficult for millions of Americans with diabetes.
Let's personalize your content